Top Sell
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.45 | - | - |
| Trevena Inc. | 2 | 23 | 0 | 0 | €0.15 | €6.48 | 4136.601% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.78 | €21.44 | 216.292% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.54 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.47 | €5.47 | 1055.424% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Immuron | 0 | 1 | 0 | 0 | €2.12 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.20 | €7.31 | 128.307% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.55 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.96 | €2.00 | 108.290% |
| Intellia Therapeutics Inc | 15 | 1 | 0 | 0 | €18.03 | €60.53 | 235.707% |
| Compugen Ltd. | 3 | 2 | 0 | 0 | €1.65 | €3.66 | 121.560% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.00 | €50.00 | 38.889% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €4.98 | €11.00 | 120.972% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 91.388% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.09 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.09 | €50.00 | 4499.816% |
| Moleculin Biotech Inc | 3 | 25 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.79 | €4.99 | 535.975% |
| Bayer AG ADR | 0 | 2 | 0 | 1 | €7.10 | €7.00 | -1.408% |
| Gritstone Oncology Inc | 7 | 1 | 1 | 0 | €0.42 | €3.65 | 759.943% |